Disturbance of autophagy-lysosome signaling molecule expression in human gastric adenocarcinoma

Area of Science:

• Oncology
• Cell Biology

Background:

• Autophagy, a type II programmed cell death, may play a role in cancer development.
• The interplay between autophagy-lysosome signaling, apoptosis, and gastric cancer remains unclear.

Purpose of the Study:

• To investigate the induction of autophagy in poorly differentiated human gastric adenocarcinoma.
• To explore the relationship between autophagic signaling and the apoptotic cascade in gastric cancer cells.

Main Methods:

• Immunoblotting was used to assess protein levels related to autophagy (LC3-I/II, Beclin 1) and lysosomal function (Lamp2, cathepsin B).
• Western blotting analyzed the expression of apoptosis-related proteins (Bcl-2, XIAP).
• Confocal laser microscopy examined the co-expression of Bcl-2 and Beclin 1.

Main Results:

• Autophagy was significantly induced in poorly differentiated gastric adenocarcinoma, evidenced by increased LC3-I/II conversion and Beclin 1.
• The diffuse subtype showed elevated levels of Lamp2 and cathepsin B, indicating enhanced lysosomal activity.
• Concomitant induction of anti-apoptotic events was observed, with increased Bcl-2 and XIAP levels.
• Co-expression of Bcl-2 and Beclin 1 was detected in poorly differentiated gastric adenocarcinoma cells.

Conclusions:

• Autophagy-lysosome signaling is involved in the pathogenesis of poorly differentiated human gastric adenocarcinoma.
• Intracellular connections exist between autophagic signaling and the apoptotic cascade in gastric cancer.